Welcome to our dedicated page for Barnwell Inds SEC filings (Ticker: BRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track Barnwell Industries’ depletion charges or land-sale gains buried deep in its 10-K? Energy accounting, reserve revisions, and contract drilling margins can stretch past 200 pages, turning routine research into a time sink.
Our platform solves that problem. Stock Titan delivers every Barnwell Industries SEC filing the moment it hits EDGAR—from the annual report 10-K to each quarterly earnings report 10-Q filing and rapid-fire 8-K material events. An AI engine translates dense footnotes into plain language, so you can move from “What does this mean?” to actionable insight in minutes. Want the latest Barnwell Industries insider trading Form 4 transactions? You’ll see Form 4 insider transactions in real time, complete with AI-powered context on executive stock moves.
Use the page to:
- Review Barnwell Industries executive stock transactions Form 4 alongside commodity-price charts.
- Compare production volumes and depletion rates across periods with our Barnwell Industries earnings report filing analysis.
- Dive into the Barnwell Industries proxy statement executive compensation without combing through legal language.
- Get notifications when a new Barnwell Industries 8-K material events explained is posted.
Whether you’re understanding Barnwell Industries SEC documents with AI for the first time or you’re a veteran investor needing quick updates, this page keeps you current, informed, and ahead of the market.
Barnwell Industries, Inc. (BRN) reported a Form 4 showing that director Joshua Horowitz received a grant of 44,445 restricted stock units on
Kenneth S. Grossman, a director of Barnwell Industries, Inc. (BRN), was granted 44,445 restricted stock units (RSUs) on
Barnwell Industries, Inc. (BRN) reported a Form 4 showing that director Philip J. McPherson was granted 44,445 restricted stock units on 10/08/2025. The award is recorded as a non‑derivative acquisition and is held directly. The filing states the grant represents a restricted stock unit award made pursuant to a Board grant to a non‑employee director. The form was signed by an attorney‑in‑fact on 10/10/2025.
The transaction increases the reporting person’s beneficial ownership by 44,445 shares as of the grant date and does not disclose an exercise price since it is an equity award rather than an option. No other securities or derivative transactions are reported on this form.
Barnwell Industries, Inc. (BRN) filed an Initial Statement of Beneficial Ownership (Form 3) reporting that Philip J. McPherson was appointed to the company's board of directors effective
Kenneth S. Grossman, a director of Barnwell Industries, Inc. (BRN), was granted 65,000 shares of common stock on
Barnwell Industries, Inc. Employees' Pension Plan Trust filed Amendment No. 1 to a Schedule 13D reporting ownership of 629,525 shares of Barnwell common stock, representing 6.2% of the 10,073,534 shares outstanding as of August 11, 2025. The filing restates the issuer's principal office and clarifies that other terms of the original Schedule 13D remain unchanged.
The trust disclosed a sequence of open-market purchases between July 14, 2025 and September 10, 2025 totaling the shares reported, with prices per share ranging from $1.12 to $1.24. The filing includes a standard disclaimer that the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
A 30% shareholder alleges that Barnwell Industries' board has spent nearly all of the company's roughly $2 million cash over six months to resist the shareholder's efforts to nominate directors, accelerating cash losses and destroying shareholder value. The filing accuses the board of selling a Texas investment at an approximately $3 million loss to raise cash, amending promissory notes tied to a water-sale payment and delaying collections, and pursuing defensive measures—including a second poison pill and legal challenges—that the shareholder says entrench management rather than protect the business.
The shareholder states willingness to discuss settlements and potential financings but says the board refused constructive solutions and blocked qualified director candidates, while the company has publicly noted it is "investigating potential sources of funding, including debt financing, issuance of stock." The filing also alleges the company’s pension plan purchased about 520,000 shares of BRN stock.